Clark Estates’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Clark Estates's UTHR Position: Q4 2025 in Review
Clark Estates sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 6,730 shares — an estimated $2.82M sold.
Clark Estates first reported a position in UTHR in Q1 2018 and held it in 17 quarters. The position peaked at $4.37M in Q3 2024. 845 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.
- Clark Estates reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
- Clark Estates sold 6,730 United Therapeutics shares in Q4 2025, an estimated $2.82M.
- Clark Estates first reported a position in United Therapeutics in Q1 2018 and held it in 17 quarters.
- Clark Estates's United Therapeutics position peaked at $4.37M in Q3 2024.
- 845 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.
Based on Clark Estates's 13F filing for Q4 2025, filed 12 Feb 2026.